1-3 of 3
Yvonne B Claassen
Close
Sort by
Journal Articles

AML-specific cytotoxic antibodies in patients with durable graft-versus-leukemia responses

Marijn A. Gillissen, Martijn Kedde, Greta de Jong, Gemma Moiset, Etsuko Yasuda, Sophie E. Levie, Arjen Q. Bakker, Yvonne B. Claassen, Koen Wagner, Martino Böhne, Paul J. Hensbergen, Dave Speijer, Pauline M. van Helden, Tim Beaumont, Hergen Spits, Mette D. Hazenberg
Journal: Blood
Blood (2018) 131 (1): 131–143.
https://doi.org/10.1182/blood-2017-02-768762
Published: 2018
Includes: Supplemental data
Journal Articles

Donor-Derived B Cells Produce Potent AML-Specific Antibodies That Recognize Novel Tumor-Specific Antigens and Mediate Graft-Versus-Leukemia Immunity

Marijn Aletta Gillissen, MD, Martijn Kedde, Etsuko Yasuda, PhD, Sophie E. Levie, Arjen Q. Bakker, Yvonne B. Claassen, Martino Bohne, Dave Speijer, PhD, Daisy I. Picavet, Jan Stap, Marinus H. J. van Oers, Tim Beaumont, PhD, Pauline M. van Helden, PhD, Hergen Spits, PhD, Mette D. Hazenberg, MD PhD
Journal: Blood
Blood (2015) 126 (23): 3146.
https://doi.org/10.1182/blood.V126.23.3146.3146
Published: 2015
Journal Articles

Unique and Potent Tumor Specific Antibodies in Graft Versus Leukemia Responses

Marijn A. Gillissen, MD, Etsuko Yasuda, PhD, Sophie Levie, Arjen Q Bakker, Martijn Kedde, Yvonne B Claassen, Cynthia Huisman, MD PhD, Hergen Spits, PhD, Tim Beaumont, PhD, Mette D. Hazenberg, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3826.
https://doi.org/10.1182/blood.V124.21.3826.3826
Published: 2014